Investing.com - J&J (NYSE:JNJ) reported fourth quarter earnings that beat analysts' expectations on Wednesday and revenue that fell short of forecasts.
The firm reported earnings per share of $1.88 on revenue of $20.75B. Analysts polled by Investing.com forecast EPS of $1.87 on revenue of $20.78B. That compared to EPS of $1.97 on revenue of $20.39B in the same period a year earlier. The company had reported EPS of $2.12 on revenue of $20.73B in the previous quarter.
For the year, J&J shares are up 2.33%, broadly in line with the Dow 30 which is up 1.95% year to date.
J&J follows other major Healthcare sector earnings this month
On Thursday, October 31, 2019, Novocure Ltd reported third quarter EPS of $0.02 on revenue of $92.06M, compared to forecasts of EPS of $-0.04 on revenue of $86.94M.
ABIOMED earnings beat analyst's expectations on Monday, January 13, 2020, with third quarter EPS of $1.09 on revenue of $221.6M. Investing.com analysts expected EPS of $1.07 on revenue of $226.67M
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar